Innovations in the Diagnosis and Management of Uveitis

Posted On 2021-12-03 14:43:13

This series on “Innovations in the Diagnosis and Management of Uveitis” is edited by Steven Yeh, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA; Emory Eye Center, Emory University School of Medicine, Atlanta, GA, USA.

We hope this special edition of Annals of Eye Science will provide the reader with broad insight on the “State-of-the-art” in uveitis and future directions to care for this complex array of ocular inflammatory diseases.

Editorial
Innovations in the diagnosis and management of uveitis: promising research to address unmet patient needs
Steven Yeh, Ye Huang, Joanne Thomas

Review Article
Update on the diagnosis and treatment of Vogt-Koyanagi-Harada syndrome
Ghazala A. Datoo O’Keefe

Uveitis secondary to cancer therapeutics
Sruthi Arepalli, Arthi G. Venkat

Pediatric uveitis: EYE-Q and metrics beyond visual acuity
Joseph M. McDonald, Steven Yeh, Sheila T. Angeles-Han

Diagnosis and treatment of autoimmune retinopathy
Henry Lin, David Dao, H. Nida Sen

Altering the intestinal microbiota for therapeutic benefit in uveitis
Phoebe Lin

Novel diagnostic imaging techniques and applications in anterior uveitis, intermediate uveitis, and scleritis
Andrew Zheng, Sumit Sharma

Biologics in non-infectious uveitis past, present and future
Amr M. Zaki, Eric B. Suhler

Advances in the diagnosis and management of acute retinal necrosis
Casey L. Anthony, J. Clay Bavinger, Steven Yeh

Update on biologic therapies for juvenile idiopathic arthritis-associated uveitis
Joanne Thomas, Sanjana Kuthyar, Jessica G. Shantha, Sheila T. Angeles-Han, Steven Yeh

Cytomegalovirus retinitis in the highly active anti-retroviral therapy era
Ifeoma N. Ude, Steven Yeh, Jessica G. Shantha

To be updated

Disclosure:
The series “Innovations in the Diagnosis and Management of Uveitis” was commissioned by the editorial office, Annals of Eye Science without any sponsorship or funding. Steven Yeh served as the unpaid Guest Editor for the series.